Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | THPO | P40225 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9149866 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL154485 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL4830684 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL4277097 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL3289586 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL79438 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL154484 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL10814176 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL344883 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL8439741 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6562606-B1 | Composition for use as tool in the transfer pharmeceutical across epithelial barriers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-05-13 | — | — | US | claimed |
| US-6190894-B1 | APPLYING INHIBITORS OF BIOSYNTHESIS OR DEGRADATION, DEGRADATION ENZYMES, AND/OR INHIBITORS AND ACTIVATORS OF METABOLIC ENZYMES; FOR TOPICAL ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE SUBSTANCES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-02-20 | — | — | US | claimed |
| WO-1998017253-A1 | METHOD AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-04-30 | — | — | WO | claimed |
| EP-0764017-A4 | METHODS AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMA INC (US) | 1997-08-06 | — | — | EP | claimed |
| EP-0764017-A1 | METHODS AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMACEUTICALS, INC. (US) | 1997-03-26 | — | — | EP | claimed |
| WO-1994021230-A1 | METHOD AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMACEUTICALS, INC. (US) | 1994-09-29 | — | — | WO | claimed |
| US-9404136-B2 | A-xylosidase enhanced conversion of plant biomass into fermentable sugars | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2016-08-02 | — | — | US | disclosed |
| US-20150337279-A1 | RECOMBINANT FUNGAL POLYPEPTIDES | SHELL OIL COMPANY | 2015-11-26 | — | — | US | disclosed |
| US-20140004572-A1 | A-XYLOSIDASE ENHANCED CONVERSION OF PLANT BIOMASS INTO FERMENTABLE SUGARS | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2014-01-02 | — | — | US | disclosed |
| US-8440449-B2 | Transformed Saccharomyces cerevisiae engineered for xylose utilization | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2013-05-14 | — | — | US | disclosed |
| US-20100112658-A1 | Transformed Saccharomyces cerevisiae Engineered for Xylose Utilization | LIFESENSORS, INC. | 2010-05-06 | — | — | US | disclosed |
| WO-2010039692-A2 | TRANSFORMED SACCHAROMYCES CEREVISIAE ENGINEERED FOR XYLOSE UTILIZATION | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2010-04-08 | — | — | WO | disclosed |
| US-6562606-B1 | Composition for use as tool in the transfer pharmeceutical across epithelial barriers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-05-13 | — | — | US | disclosed |
| US-6190894-B1 | APPLYING INHIBITORS OF BIOSYNTHESIS OR DEGRADATION, DEGRADATION ENZYMES, AND/OR INHIBITORS AND ACTIVATORS OF METABOLIC ENZYMES; FOR TOPICAL ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE SUBSTANCES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-02-20 | — | — | US | disclosed |
| US-5824533-A | GENETIC ENGINEERING, GENE EXPRESSION | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1998-10-20 | — | — | US | disclosed |
| EP-0764017-A4 | METHODS AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMA INC (US) | 1997-08-06 | — | — | EP | disclosed |
| EP-0764017-A1 | METHODS AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMACEUTICALS, INC. (US) | 1997-03-26 | — | — | EP | disclosed |
| WO-1994021230-A1 | METHOD AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMACEUTICALS, INC. (US) | 1994-09-29 | — | — | WO | disclosed |